Evidence map›Paper›PMID 35003575›Full record

ReviewChemical science2021

The 100 facets of the Passerini reaction.

Luca Banfi, Andrea Basso, Chiara Lambruschini, Lisa Moni, Renata Riva

Abstract readReview
In one paragraph

Review in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Review
  2. Article
  3. Multicomponent Reactions for the Synthesis of Oxazepines.Topics in current chemistry (Cham) · 2026
    Review
  4. Article
  5. Article
  6. Harnessing PNature communications · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Total Synthesis of 4-Molecules (Basel, Switzerland) · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Luca BanfiDepartment of Chemistry and Industrial Chemistry, University of Genova Via Dodecaneso 31 16146 Genova Italy luca.banfi@unige.it.ORCID https://orcid.org/0000-0001-7605-0993
Andrea BassoDepartment of Chemistry and Industrial Chemistry, University of Genova Via Dodecaneso 31 16146 Genova Italy luca.banfi@unige.it.ORCID https://orcid.org/0000-0002-4700-1823
Chiara LambruschiniDepartment of Chemistry and Industrial Chemistry, University of Genova Via Dodecaneso 31 16146 Genova Italy luca.banfi@unige.it.ORCID https://orcid.org/0000-0003-1447-2650
Lisa MoniDepartment of Chemistry and Industrial Chemistry, University of Genova Via Dodecaneso 31 16146 Genova Italy luca.banfi@unige.it.ORCID https://orcid.org/0000-0001-5149-2963
Renata RivaDepartment of Chemistry and Industrial Chemistry, University of Genova Via Dodecaneso 31 16146 Genova Italy luca.banfi@unige.it.ORCID https://orcid.org/0000-0002-0829-9444

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This perspective aims at celebrating the 100th anniversary of the discovery of the Passerini three component reaction. After being nearly neglected for many years, now this reaction has become quite popular, thanks to the achievements of the last 30 years, which have revealed several chances of exploitation in organic synthesis. Though not being comprehensive, this review means to show the various ways that have been used in order to expand the utility of the Passerini reaction. Post-MCR transformations to give heterocycles or peptidomimetics, variants through single component replacement, stereochemical issues, and applications in total syntheses will be especially covered.

Identifiers

PMID35003575
PMCPMC8654045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.